Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Head and Neck Squamous Cell Carcinoma · Hypopharyngeal Squamous Cell Carcinoma · Laryngeal Squamous Cell Carcinoma · Nasopharyngeal Squamous Cell Carcinoma · Oral Cavity Squamous Cell Carcinoma · Oropharyngeal Squamous Cell Carcinoma · Stage 0 Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 · Stage 0 Hypopharyngeal Carcinoma AJCC v8 · Stage 0 Nasopharyngeal Carcinoma AJCC v8 · Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8 · Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 · Stage I Hypopharyngeal Carcinoma AJCC v8 · Stage I Laryngeal Cancer AJCC v8 · Stage I Lip and Oral Cavity Cancer AJCC v8 · Stage I Nasopharyngeal Carcinoma AJCC v8 · Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8 · Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 · Stage II Hypopharyngeal Carcinoma AJCC v8 · Stage II Laryngeal Cancer AJCC v8 · Stage II Lip and Oral Cavity Cancer AJCC v8 · Stage II Nasopharyngeal Carcinoma AJCC v8 · Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8 · Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 · Stage III Hypopharyngeal Carcinoma AJCC v8 · Stage III Laryngeal Cancer AJCC v8 · Stage III Lip and Oral Cavity Cancer AJCC v8 · Stage III Nasopharyngeal Carcinoma AJCC v8 · Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 · Stage IVA Hypopharyngeal Carcinoma AJCC v8 · Stage IVA Laryngeal Cancer AJCC v8 · Stage IVA Lip and Oral Cavity Cancer AJCC v8 · Stage IVA Nasopharyngeal Carcinoma AJCC v8 · Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 · Stage IVB Hypopharyngeal Carcinoma AJCC v8 · Stage IVB Laryngeal Cancer AJCC v8 · Stage IVB Lip and Oral Cavity Cancer AJCC v8 · Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8 · Stomatitis

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Arizona Center for Cancer Care - Gilbert, Gilbert, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · penny.labriola@arizonaccc.com · 480-278-8261
    Contact: Principal Investigator (Steven E. Sckolnik)
  • Arizona Center for Cancer Care-Peoria, Peoria, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · 623-773-2873
    Contact: Principal Investigator (Steven E. Sckolnik)
  • Arizona Center for Cancer Care - Phoenix, Phoenix, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · penny.labriola@arizonaccc.com · 480-278-8261
    Contact: Principal Investigator (Steven E. Sckolnik)
  • Arizona Center for Cancer Care - Scottsdale, Scottsdale, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · penny.labriola@arizonaccc.com · 480-278-8261
    Contact: Principal Investigator (Steven E. Sckolnik)
  • Arizona Center for Cancer Care-Surprise, Surprise, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Steven E. Sckolnik)
  • Arizona Center for Cancer Care, Tempe, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · penny.labriola@arizonaccc.com · 480-278-8261
    Contact: Principal Investigator (Steven E. Sckolnik)
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · Emily.Carvell@bmhcc.org · 870-936-7066
    Contact: Principal Investigator (Shelby Lane)
  • Keck Medicine of USC Buena Park, Buena Park, California, United States

  • UC San Diego Health System - Encinitas, Encinitas, California, United States

    Contact: Study coordinator (Site Public Contact) · 760-536-7700
    Contact: Principal Investigator (Karen M. Yun)
  • UC San Diego Moores Cancer Center, La Jolla, California, United States

    Contact: Study coordinator (Site Public Contact) · cancercto@ucsd.edu · 858-822-5354
    Contact: Principal Investigator (Karen M. Yun)
  • Los Angeles General Medical Center, Los Angeles, California, United States

  • USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

  • USC Norris Oncology/Hematology-Newport Beach, Newport Beach, California, United States

  • UC San Diego Medical Center - Hillcrest, San Diego, California, United States

    Contact: Study coordinator (Site Public Contact) · rhabbaba@health.ucsd.edu
    Contact: Principal Investigator (Karen M. Yun)
  • Shaw Cancer Center, Edwards, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-569-7429
    Contact: Principal Investigator (Patricia H. Hardenbergh)
  • George Washington University Medical Center, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · 202-741-2210
    Contact: Principal Investigator (Sharad Goyal)
  • Sarasota Memorial Hospital-Venice, N. Venice, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 941-261-9000
    Contact: Principal Investigator (Kunal Saigal)
  • Moffitt Cancer Center at SouthShore, Ruskin, Florida, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalTrials@moffitt.org · 800-679-0775
    Contact: Principal Investigator (Niema B. Razavian)
  • Florida Cancer Specialists - Sarasota, Sarasota, Florida, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Kunal Saigal)
  • Florida Cancer Specialists - Sarasota Downtown, Sarasota, Florida, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalTrials@FLCancer.com · 239-274-9930
    Contact: Principal Investigator (Kunal Saigal)
  • Sarasota Memorial Hospital, Sarasota, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 941-917-2225
    Contact: Principal Investigator (Kunal Saigal)
  • Sarasota Memorial Health Care Center at University Parkway, Sarasota, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 941-917-6519
    Contact: Principal Investigator (Kunal Saigal)
  • Moffitt Cancer Center-International Plaza, Tampa, Florida, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalTrials@moffitt.org · 800-679-0775
    Contact: Principal Investigator (Niema B. Razavian)
  • Moffitt Cancer Center - McKinley Campus, Tampa, Florida, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalTrials@moffitt.org · 800-679-0775
    Contact: Principal Investigator (Niema B. Razavian)
  • Moffitt Cancer Center, Tampa, Florida, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalTrials@moffitt.org · 800-679-0775
    Contact: Principal Investigator (Niema B. Razavian)
  • Florida Cancer Specialists - Venice Pinebrook, Venice, Florida, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalTrials@FLCancer.com · 239-274-9930
    Contact: Principal Investigator (Kunal Saigal)
  • Moffitt Cancer Center at Wesley Chapel, Wesley Chapel, Florida, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalTrials@moffitt.org · 800-679-0775
    Contact: Principal Investigator (Niema B. Razavian)
  • OSF Saint Joseph Medical Center, Bloomington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Bloomington, Bloomington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Canton, Canton, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern University, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancer@northwestern.edu · 312-695-1301
    Contact: Principal Investigator (Laila A. Gharzai)
  • Carle at The Riverfront, Danville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Sinisa Stanic)
  • Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Laila A. Gharzai)
  • Carle Physician Group-Effingham, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Sinisa Stanic)
  • Illinois CancerCare-Eureka, Eureka, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Galesburg, Galesburg, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Laila A. Gharzai)
  • Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Macomb, Macomb, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Sinisa Stanic)
  • Northwestern Medicine Oak Brook, Oak Brook, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · nctnprogram_rhlccc@northwestern.edu
    Contact: Principal Investigator (Laila A. Gharzai)
  • Northwestern Medicine Orland Park, Orland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · nctnprogram_rhlccc@northwestern.edu
    Contact: Principal Investigator (Laila A. Gharzai)
  • Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Pekin, Pekin, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Peoria, Peoria, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • OSF Saint Francis Medical Center, Peoria, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Peru, Peru, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Princeton, Princeton, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Cancer Center, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Sinisa Stanic)
  • Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Laila A. Gharzai)
  • Illinois CancerCare - Washington, Washington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Baptist Health Floyd, New Albany, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (William A. Porter)
  • McFarland Clinic - Ames, Ames, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · ksoder@mcfarlandclinic.com · 515-239-4734
    Contact: Principal Investigator (Joseph J. Merchant)
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Mercy Hospital, Cedar Rapids, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 319-365-4673
    Contact: Principal Investigator (Deborah W. Wilbur)
  • Oncology Associates at Mercy Medical Center, Cedar Rapids, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 319-363-2690
    Contact: Principal Investigator (Deborah W. Wilbur)
  • UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Iowa Methodist Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-6727
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Mercy Medical Center - Des Moines, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Richard L. Deming)
  • UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 800-237-1225
    Contact: Principal Investigator (Carryn M. Anderson)
  • UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • University of Kansas Cancer Center, Kansas City, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Christopher Lominska)
  • Salina Regional Health Center, Salina, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · mleepers@srhc.com · 785-452-7038
    Contact: Principal Investigator (Christopher Lominska)
  • University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Christopher Lominska)
  • Baptist Health Hardin, Elizabethtown, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · 270-706-5470
    Contact: Principal Investigator (William A. Porter)
  • Greater Baltimore Medical Center, Baltimore, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · 443-849-3706
    Contact: Principal Investigator (Kruti Patel)
  • Boston Medical Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 617-638-8265
    Contact: Principal Investigator (Minh T. Truong)
  • McLaren Cancer Institute-Bay City, Bay City, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Brian K. Yeh)
  • McLaren Cancer Institute-Clarkston, Clarkston, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Brian K. Yeh)
  • Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 800-527-6266
    Contact: Principal Investigator (Brian K. Yeh)
  • Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Brian K. Yeh)
  • McLaren Cancer Institute-Flint, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Brian K. Yeh)
  • Karmanos Cancer Institute at McLaren Greater Lansing, Lansing, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Brian K. Yeh)
  • McLaren Cancer Institute-Lapeer Region, Lapeer, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Brian K. Yeh)
  • McLaren Cancer Institute-Macomb, Mount Clemens, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Brian K. Yeh)
  • McLaren Cancer Institute-Central Michigan, Mount Pleasant, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Brian K. Yeh)
  • McLaren Cancer Institute-Northern Michigan, Petoskey, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Brian K. Yeh)
  • McLaren-Port Huron, Port Huron, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Brian K. Yeh)
  • Miller-Dwan Hospital, Duluth, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus, Mississippi, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Shelby Lane)
  • Baptist Cancer Center-Grenada, Grenada, Mississippi, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Shelby Lane)
  • Baptist Memorial Hospital and Cancer Center-Union County, New Albany, Mississippi, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Shelby Lane)
  • Baptist Memorial Hospital and Cancer Center-Oxford, Oxford, Mississippi, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Shelby Lane)
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven, Mississippi, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Shelby Lane)
  • Saint Francis Medical Center, Cape Girardeau, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · sfmc@sfmc.net · 573-334-2230
    Contact: Principal Investigator (Bryan A. Faller)
  • Lake Regional Hospital, Osage Beach, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@lakeregional.com · 573-302-2768
    Contact: Principal Investigator (Jay W. Carlson)
  • Renown Regional Medical Center, Reno, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (Abhinand V. Peddada)
  • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire, United States

    Contact: Study coordinator (Site Public Contact) · cancer.research.nurse@dartmouth.edu · 800-639-6918
    Contact: Principal Investigator (Philip E. Schaner)
  • University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

    Contact: Study coordinator (Site Public Contact) · HSC-ClinicalTrialInfo@salud.unm.edu · 505-925-0348
    Contact: Principal Investigator (Moises Harari-Turquie)
  • Montefiore Medical Center-Einstein Campus, The Bronx, New York, United States

    Contact: Study coordinator (Site Public Contact) · eskwak@montefiore.org · 718-379-6866
    Contact: Principal Investigator (Rafi Kabarriti)
  • Montefiore Medical Center - Moses Campus, The Bronx, New York, United States

    Contact: Study coordinator (Site Public Contact) · eskwak@montefiore.org · 718-379-6866
    Contact: Principal Investigator (Rafi Kabarriti)
  • Atrium Health Stanly/LCI-Albemarle, Albemarle, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Matthew C. Ward)
  • Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Matthew C. Ward)
  • Atrium Health Pineville/LCI-Pineville, Charlotte, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 980-442-2000
    Contact: Principal Investigator (Matthew C. Ward)
  • Atrium Health University City/LCI-University, Charlotte, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Matthew C. Ward)
  • Atrium Health Cabarrus/LCI-Concord, Concord, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Matthew C. Ward)
  • Duke University Medical Center, Durham, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 888-275-3853
    Contact: Principal Investigator (Jared R. Robbins)
  • CaroMont Regional Medical Center, Gastonia, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · tammy.cozad@caromonthealth.org · 704-834-2810
    Contact: Principal Investigator (Jeffrey G. Kuremsky)
  • Levine Cancer Institute-Gaston, Gastonia, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Matthew C. Ward)
  • Hayworth Cancer Center, High Point, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 336-802-2500
    Contact: Principal Investigator (Ryan T. Hughes)
  • Atrium Health Union/LCI-Union, Monroe, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 980-442-2000
    Contact: Principal Investigator (Matthew C. Ward)
  • Atrium Health Cleveland/LCI-Cleveland, Shelby, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Matthew C. Ward)
  • Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 336-713-6771
    Contact: Principal Investigator (Ryan T. Hughes)
  • Summa Health System - Akron Campus, Akron, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · cancerresearch@summahealth.org · 330-375-4221
    Contact: Principal Investigator (Desiree E. Doncals)
  • Aultman Health Foundation, Canton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalReserachDept@aultman.com · 330-363-7274
    Contact: Principal Investigator (Jessica L. Wobb)
  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · cancer@uchealth.com · 513-584-7698
    Contact: Principal Investigator (Sara Medek)
  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jamesline@osumc.edu · 800-293-5066
    Contact: Principal Investigator (Sung Jun Ma)
  • University of Cincinnati Cancer Center-West Chester, West Chester, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · cancer@uchealth.com · 513-584-7698
    Contact: Principal Investigator (Sara Medek)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · ou-clinical-trials@ouhsc.edu · 405-271-8777
    Contact: Principal Investigator (Christina Henson)
  • Chambersburg Hospital, Chambersburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Amit B. Shah)
  • Ephrata Cancer Center, Ephrata, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 717-721-4840
    Contact: Principal Investigator (Amit B. Shah)
  • UPMC Hillman Cancer Center Erie, Erie, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalResearchServices@upmc.edu · 412-864-7716
    Contact: Principal Investigator (Yvonne M. Mowery)
  • UPMC Cancer Center at UPMC Horizon, Farrell, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Yvonne M. Mowery)
  • Adams Cancer Center, Gettysburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 877-441-7957
    Contact: Principal Investigator (Amit B. Shah)
  • UPMC Cancer Centers - Arnold Palmer Pavilion, Greensburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 724-838-1900
    Contact: Principal Investigator (Yvonne M. Mowery)
  • UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Harrisburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · klitchfield@PINNACLEHEALTH.org · 717-724-6765
    Contact: Principal Investigator (Yvonne M. Mowery)
  • Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · CTO@hmc.psu.edu · 717-531-3779
    Contact: Principal Investigator (Min Yao)
  • Sechler Family Cancer Center, Lebanon, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · doxenberg@wellspan.org · 717-741-8303
    Contact: Principal Investigator (Amit B. Shah)
  • UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion, Mechanicsburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · haneydl@upmc.edu · 412-389-5208
    Contact: Principal Investigator (Yvonne M. Mowery)
  • UPMC Cancer Center - Monroeville, Monroeville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Yvonne M. Mowery)
  • UPMC Hillman Cancer Center - Monroeville, Monroeville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalResearchServices@upmc.edu · 412-864-7716
    Contact: Principal Investigator (Yvonne M. Mowery)
  • UPMC Hillman Cancer Center - New Castle, New Castle, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · haneydl@upmc.edu · 412-389-5208
    Contact: Principal Investigator (Yvonne M. Mowery)
  • UPMC-Saint Margaret, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-784-4900
    Contact: Principal Investigator (Yvonne M. Mowery)
  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-647-8073
    Contact: Principal Investigator (Yvonne M. Mowery)
  • UPMC-Shadyside Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-621-2334
    Contact: Principal Investigator (Yvonne M. Mowery)
  • UPMC-Passavant Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-367-6454
    Contact: Principal Investigator (Yvonne M. Mowery)
  • UPMC-Saint Clair Hospital Cancer Center, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-502-3920
    Contact: Principal Investigator (Yvonne M. Mowery)
  • WellSpan Health-York Cancer Center, York, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 877-441-7957
    Contact: Principal Investigator (Amit B. Shah)
  • Lancaster Radiation Therapy Center, Lancaster, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Matthew C. Ward)
  • Rock Hill Radiation Therapy Center, Rock Hill, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Matthew C. Ward)
  • Levine Cancer Institute-Rock Hill, Rock Hill, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Matthew C. Ward)
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Shelby Lane)
  • University of Tennessee - Knoxville, Knoxville, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · 865-544-9773
    Contact: Principal Investigator (Christopher Brett)
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Shelby Lane)
  • Dartmouth Cancer Center - North, Saint Johnsbury, Vermont, United States

    Contact: Study coordinator (Site Public Contact) · cancer.research.nurse@hitchcock.org · 800-639-6918
    Contact: Principal Investigator (Philip E. Schaner)
  • VCU Massey Cancer Center at Stony Point, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · ctoclinops@vcu.edu
    Contact: Principal Investigator (Erin R. Alesi)
  • VCU Massey Comprehensive Cancer Center, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · CTOclinops@vcu.edu · 804-628-6430
    Contact: Principal Investigator (Erin R. Alesi)
  • Langlade Hospital and Cancer Center, Antigo, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Juli.Alford@aspirus.org · 715-623-9869
    Contact: Principal Investigator (Andrew J. Huang)
  • Northwest Wisconsin Cancer Center, Ashland, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Froedtert Menomonee Falls Hospital, Menomonee Falls, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-257-5100
    Contact: Principal Investigator (Musaddiq J. Awan)
  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-3666
    Contact: Principal Investigator (Musaddiq J. Awan)
  • Zablocki Veterans Administration Medical Center, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 888-469-6614
    Contact: Principal Investigator (Evan Liang)
  • ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States

  • Drexel Town Square Health Center, Oak Creek, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-0505
    Contact: Principal Investigator (Musaddiq J. Awan)
  • ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States

  • Aspirus Cancer Care - James Beck Cancer Center, Rhinelander, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Beth.Knetter@aspirus.org · 715-847-2353
    Contact: Principal Investigator (Andrew J. Huang)
  • Aspirus Cancer Care - Stevens Point, Stevens Point, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Beth.Knetter@aspirus.org · 715-847-2353
    Contact: Principal Investigator (Andrew J. Huang)
  • UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States

  • Aspirus Regional Cancer Center, Wausau, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 877-405-6866
    Contact: Principal Investigator (Andrew J. Huang)
  • Froedtert West Bend Hospital/Kraemer Cancer Center, West Bend, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-0505
    Contact: Principal Investigator (Musaddiq J. Awan)
  • Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 715-422-7718
    Contact: Principal Investigator (Andrew J. Huang)
מובילי המחקר
  • David M Brizel

    Principal Investigator

    NRG Oncology